„‘E˜_•¶@

Presented by HIROYUKI KOUMI
(Last Update 2019/4/16)

‘Ûf’fŠî€

  1. Diagnostic and Statistical Manual-‡W-TR(DSM-‡W-TR)
    1) American Psychiatric Association (2000)F Quick reference to the diagnostic criteria from DSM-‡W-TR. ‚‹´ŽO˜YE‘å–ì —TEõ–îrK(–ó) (2003): DSM-‡W-TR¸_Ž¾Š³‚Ì•ª—Þ‚Æf’f‚ÌŽèˆø V’ù”Å ˆãŠw‘‰@

  2. Diagnostic and Statistical Manual-Fifth Edition(DSM-5)
    American Psychiatric Association (2013): Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association. “ú–{¸__ŒoŠw‰ï(“ú–{Œê”Å—pŒêŠÄC)Eûü‹´ŽO˜YE‘å–ì —T(ŠÄ–ó)Eõ–îrKE_’ëdME”öè‹I•vEŽO‘º ›’E‘ºˆärÆ(–ó) (2014): DSM-5 ¸_Ž¾Š³‚Ìf’fE“Œvƒ}ƒjƒ…ƒAƒ‹. ˆãŠw‘‰@

  3. International Classification of Diseases-10(ICD-10)
    1) World Health Organization (1992): The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO. —Z “¹’jE’†ªˆò•¶E¬Œ©ŽR ŽÀ(ŠÄ–ó): ICD-10¸_‚¨‚æ‚Ñs“®‚ÌáŠQ|—Õ°‹Lq‚Æf’fƒKƒCƒhƒ‰ƒCƒ“ ˆãŠw‘‰@

  4. International Classification of Diseases-11th Revision (ICD-11)
    1) World Health Organization (2018)

  5. National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA)
    1) McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's diseaseFreport of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseDNeurology, 34, 939-944.

  6. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN)
    1) Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, OfBrien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993): Vascular dementiaFdiagnostic criteria for research studiesFreport of the NINDS-AIREN International WorkshopDNeurology, 43, 250-260.

  7. National Institute of Neurological Disorders and Stroke-Society for Progressive Supranuclear Palsy (NINDS-SPSP)
    1) Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996): Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47, 1-9.

  8. Dementia with Lewy Bodies (DLB)
    1) McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB (2005): Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology, 65, 1863-1872.

  9. Frontotemporal Dementia (FTD)
    1) The Lund and Manchester Groups (1994): Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 57, 416-418.
    2) Mckhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001): Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Archives of Neurology, 58, 1803-1809.

  10. Fromtotemporal Lobar Degeneration (FTLD)
    1) Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998): Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546-1554.

  11. Mild Cognitive Impairment (MCI)
    1) Petersen RC (2004): Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183-194.

_ŒoS—ŒŸ¸

  1. Autobiographical Memory Interview (ABMT)
    1) Kopelman MD, Wilson BA, Baddeley AD (1989): The autobiographical memory interview: a new assessment of autobiographical and semantic memory in amnesic patients. Journal of Clinical and Experimental Neuropsychology 11, 724-744.
    2) ‹g‰vt•vE‰Á“¡Œ³ˆê˜YEŽO‘º ›’EŽá¼’¼Ž÷EÖ“¡•¶ŒbEŽ­“‡°—YEóˆä¹O (1998): ‰“Šu‹L‰¯‚Ì_ŒoS—Šw“I•]‰¿. Ž¸ŒêÇŒ¤‹† 18, 205-214.

  2. Alzheimer's Disease Assessment Scale (ADAS)
    1) Mohs RCCRosen WGCDavis KL (1983): The Alzheimer's Disease Assessment ScaleFan instrument for assessing treatment efficacyDPsychopharmacol Bull 19, 448-450.
    2) –{ŠÔ º, •Ÿ‘òˆê‹g, ’Ë“c—Ç—Y, Έä“O˜Y, ’·’Jì˜a•v, Mohs RC (1992)FAlzheimer's Disease Assessment Scale (ADAS)“ú–{”Å‚Ìì¬D˜V”N¸_ˆãŠwŽGŽ, 3, 647-655.

  3. Barthel Index
    1) Mahoney FICBarthel DW (1965): Functional evaluationFThe Barthel IndexDMd State Med J, 14, 61-65.

  4. Baumtest
    1) ¬—Ñ•qŽq (1990): ƒoƒEƒ€ƒeƒXƒg‚É‚Ý‚é‰Á—î‚ÌŒ¤‹†F¶—“I‰Á—î‚ƃAƒ‹ƒcƒnƒCƒ}[Œ^’s•ð‚É‚Ý‚ç‚ê‚éŽ÷–؉æ‚̕ω»‚ÌŒŸ“¢D ¸__ŒoŠwŽGŽC92C22-58D

  5. Clinical Dementia Rating (CDR)
    1) Hughes CPCBerg LCDanziger WL et al. (1982): A New Clinical Scale for the Staging of DementiaDBrit J Psychiat, 140, 566-572.

  6. Clock Drawing Test (CDT)
    1) Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K (1992): Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's diseaseDBrain and cognition, 18, 70-87.
    2) Royall DR, Cordes JA, Polk M (1998): CLOX: an executive clock drawing task. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 588-594.

  7. Edinburgh Handedness Inventory
    1) Oldfield RC (1971): The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia, 9, 97-113.

  8. Frontal Assessment Battery (FAB)
    1) Dubois B, Slachevsky A, Litvan I, Pillon B (2000): The FAB: a frontal assessment battery at bedside. NeurologyC55,1621-1626D
    2) Kugo ACTerada S, Ata T, Ido Y, Kado Y, Ishihara T, Hikiji M, Fujisawa Y, Sasaki K, Kuroda S (2007): Japanese version of the Frontal Assessment Battery for dementia. Psychiatry ResearchC153, 69-75.
    3) ‘O“‡Lˆê˜Y, Ží‘º ƒ, ‘å‘òˆ¤Žq, 쌴“c”ü•Û, ŠÖŒûŒb—˜, ”‘q “O (2006): ‚—îŽÒ‚ɑ΂·‚éFrontal assessment battery(FAB)‚Ì—Õ°ˆÓ‹`‚ɂ‚¢‚ÄD”]‚Æ_ŒoC58(3),207-211.
    4) ‚–Ø—ŒbŽq, Š–{‰ê‹`, _‹g‚µ‚©, ŽO—Ö‰pl, ‹ß“¡’q‘P (2002): ‘O“ª—tŠÈˆÕ‹@”\ŒŸ¸(FAB): ƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚¨‚¯‚錟“¢D”]‚Æ_ŒoC54(10),897-902.

  9. Gerontological Apperception Test (GAT)
    1) Wolk RLCWolk RB (1971): The Gerontological Apperception Test. Behavioral Publications, New York.

  10. Hasegawa Dementia Scale (HDS)
    1) ’·’Jì˜a•vEˆä㟖çEŽç‰®‘Œõ (1974): ˜Vl‚Ì’s•ðf¸ƒXƒP[ƒ‹‚̈ꌟ“¢. ¸_ˆãŠw, 16, 965-969.

  11. Hasegawa Dementia Scale-Revised (HDS-R)
    1) ‰Á“¡LŽiE‰ºŠ_ ŒõE¬–쎛“ÖŽuEA“cGŽ÷E˜V쌫ŽOE’r“cˆê•FE¬â“Ö“ñE¡ˆäK[E’·’Jì˜a•v (1991): ‰ü’ù’·’J쎮ŠÈˆÕ’m”\•]‰¿ƒXƒP[ƒ‹(HDS-R)‚Ìì¬. ˜V”N¸_ˆãŠwŽGŽ, 2, 1339-1347.

  12. Instrumental Activities of Daily Living (I-ADL)
    1) Lawton MPCBrody EM (1969): Assessment of older peopleFself-maintaining and instrumental activities of daily livingDGerontologist, 9, 179-186.

  13. Mini-Mental State Examination (MMSE)
    1) Folstein MF, Folstein SE, McHugh PR (1975): "Mini-Mental State"Fa practical method for grading the cognitive state of patients for the clinicianDJ Psychiatr Res, 12, 189-198.
    2) X ‰x˜NEŽO’J—mŽqEŽR’¹ d (1985): _ŒoŽ¾Š³Š³ŽÒ‚É‚¨‚¯‚é“ú–{Œê”ÅMini-Mental StateƒeƒXƒg‚Ì—L—p«D_ŒoS—Šw, 1, 82-90.
    3) ‰Á“¡LŽiC–{ŠÔ º (1991): Mini-Mental State ExaminationD—Õ°¸_ˆãŠw, 20, 687-689.
    4) –k‘ºr‘¥ (1991): Mini-Mental StateD‘å’Ër’jC–{ŠÔ º(ŠÄC): ‚—îŽÒ‚Ì‚½‚ß‚Ì’m“I‹@”\ŒŸ¸‚ÌŽèˆø‚«. ƒ[ƒ‹ƒhƒvƒ‰ƒ“ƒjƒ“ƒO, pp35-38.,
    5) ¬ŠCG”V, ’©”ä“Þ‹±Žq, ‰ª‘ºD, Έä’C“ñ, “Œ ^ˆê˜Y, ‹g“c Ë, ’Óc´d (2001): “ú–{Œê”ÅMini-Mental State Examination-Aino‚ÌdÇ“x”»•ÊŠî€. —•–ìŠw‰@‹I—vC14, 59°66D
    6) ¬ŠCG”V (2004): “ú–{Œê”ÅMMSE‚É‚¨‚¯‚éSerial 7's‚Ì‘ã‘Ö–â‘è‚ɂ‚¢‚Ä‚ÌŒŸ“¢ -’PŒê‹t¥‚Æ”Žš‹t¥‚ð—p‚¢‚Ä-. ŠÖ¼‘åŠwS—‘Š’kŽº‹I—v, 5, 21-24.
    7) ¬ŠCG”V, ‰ª‘ºD, Žñ“¡ Œ«, ‘O“c–¾Žq (2008): “ú–{Œê”ÅMMSE‚É‚¨‚¯‚é•œ¥–â‘è‚ɂ‚¢‚Ä‚ÌŒŸ“¢: 4•¶ß•œ¥‚Æ5•¶ß•œ¥‚ð—p‚¢‚Ä. ŠÖ¼‘åŠwS—‘Š’kŽº‹I—v, 10, 81-87.
    8) ¬ŠCG”V, ‘O“c–¾Žq, ŽR–{ ˆ¤, ‰Á“¡—C‰À, ‰ª‘ºD, ‰€“c ŒO, ˆÀ“¡‰xŽq, ŠÝì—Y‰î (2010): “ú–{Œê”ÅMMSE‚ÌŒŸo—Í‚Æ“ÁˆÙ«‚ɂ‚¢‚Ä. ‰Ô‰€‘åŠwŽÐ‰ï•ŸŽƒŠw•”Œ¤‹†‹I—v, 18, 91-95.
    9) Psychological Assessment Resources, Inc. (2001): MMSE. MiniMental, LLC. ™‰ºŽçO (2012): Mini Mental State Examination-Japanese (MMSE-J)|¸_ó‘Ô’ZŽžŠÔŒŸ¸|“ú–{”Å “ú–{•¶‰»‰ÈŠwŽÐ
    10) ™‰ºŽçO, ˆíŒ© Œ÷, ’|“à‹ïŽq (2016): ¸_ó‘Ô’ZŽžŠÔŒŸ¸-“ú–{”Å (MMSE-J) ‚̑Ó–«‚ÆM—Š«‚ÉŠÖ‚·‚éÄŒŸ“¢. ”F’m_Œo‰ÈŠw, 18, 168-183.
    11) ™‰ºŽçO, ˜’Ë—m‰î, {“¡TŽ¡, ™‰º˜a‰º, ˆíŒ© Œ÷, “‚àVGŽ¡, ’–Œ´‹§Žj, ’©“c —², ŽOŒ´ ”Õ (2018): MMSE-J (¸_ó‘Ô’ZŽžŠÔŒŸ¸-“ú–{”Å) Œ´–@‚̑Ó–«‚ÆM—Š«. ”F’m_Œo‰ÈŠw, 20, 91-110.

  14. Montreal cognitive assessment (MoCA)
    1) Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005): The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695-699.
    2) Luis CA, Keegan AP, Mullan M (2009): Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry, 24, 197-201.

  15. Neurobehavioral Cognitive Status Examination (COGNISTAT)
    1) Kiernan RJ, Mueller J, Langston JW, Van Dyke C (1987): The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Annals of Internal Medicine, 107, 481-485.
    2) The Northern California Neurobehavioral Group (1995): Neurobehavioral Cognitive Status Examination (COGNISTAT). The Northern California Neurobehavioral Group Inc, CA.
    3) ¼“c C, ’†’JŽO•ÛŽq (2004): “ú–{Œê”ÅCOGNISTATŒŸ¸ƒ}ƒjƒ…ƒAƒ‹ ƒ[ƒ‹ƒhƒvƒ‰ƒ“ƒjƒ“ƒO

  16. Nishimura@Dementia Scale (NDS)
    1) •Ÿ‰i’mŽq, ¼‘º Œ’, ”dŒû”V˜N, ˆäã Œ’, ‰º‰Í“à–«, “ŠÎ•ÛœA, ˆäã C, ‰LŽ” ‘, “à“¡“¹•v, ¬—Ñ•qŽq, ’JŒû“T’j, “‡“c C, ˆî‰ª ’·, –ì“crì (1988): V‚µ‚¢˜Vl—p¸_‹@”\ŒŸ¸‚Ìì¬|NŽ®¸_‹@”\ŒŸ¸D˜V”N¸_ˆãŠw, 5, 221-231.

  17. Nishimura@Dementia Test (NDT)
    1) Fukunaga T, Ukai S, Kobayashi T, Nishimura T, Takeda M (2006): Neuropsychological test for the detection of dementia in elderly individuals: the Nishimura dementia test. Psychogeriatrics, 6, 159-167.

  18. NM-Scale, N-ADL
    1) ¬—Ñ•qŽqE”dŒû”V˜NE¼‘º Œ’‚Ù‚© (1988): s“®ŠÏŽ@‚É‚æ‚é’s•ðŠ³ŽÒ‚̸_ó‘Ô•]‰¿ŽÚ“x(NMƒXƒP[ƒ‹)‚¨‚æ‚Ñ“úí¶Šˆ“®ì”\—Í•]‰¿ŽÚ“x(N-ADL)‚Ìì¬D—Õ°¸_ˆãŠw, 17, 1653-1668.

  19. Repeatable battery for the Assessment of Neuropsychological States (RBANS)
    1) ¼ˆäŽOŽ} (2009): “ú–{Œê”Å_ŒoS—ŒŸ¸RBANS•W€‰»Œ¤‹†: •W€’l‚ɂ‚¢‚Ä. •xŽR‘åŠw™’JƒLƒƒƒ“ƒpƒXˆê”Ê‹³ˆçŒ¤‹†‹I—v, 37, 31-53.
    2) ¼ˆäŽOŽ}, Š}ˆä—Iˆê, ’·è^—œŒb (2010): “ú–{Œê”Å_ŒoS—ŒŸ¸RBANS‚ÌM—Š«‚ƑÓ–«. •xŽR‘åŠwˆãŠw‰ïŽ, 21, 31-36.
    3) ¼ˆäŽOŽ}, ’·è^—œŒb, Š}ˆä—Iˆê (2010): “ú–{Œê”Å_ŒoS—ŒŸ¸RBANS‚Ì•W€‰»Œ¤‹†(2): Šî‘bŽ‘—¿A‰ü’ù•W€’l‚¨‚æ‚ÑŠ·ŽZ•\. •xŽR‘åŠw™’JƒLƒƒƒ“ƒpƒXˆê”Ê‹³ˆçŒ¤‹†‹I—v, 38, 87-133.
    4) ¼ˆäŽOŽ}, ’·è^—œŒb, Š}ˆä—Iˆê (2011): “ú–{Œê”Å_ŒoS—ŒŸ¸RBANS‚Ì•W€‰»Œ¤‹†(3): ‘Žw•W. •xŽR‘åŠw™’JƒLƒƒƒ“ƒpƒXˆê”Ê‹³ˆçŒ¤‹†‹I—v, 39, 17-30.
    5) Randolph C, Tierney MC, Mohr E, Chase TN (1998): The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of Clinical Experimental Neuropsychology, 20, 310-319.
    6) Randolph C (1998): RBANS Manual-Repeatable Battery for the Assessment of Neuropsychological Status. Texas. Psychological Corporation. Harcourt.
    7) ŽRè“N·, ‹g“c^“Þ”ü, ŒF‹´ˆê•F, ¼ˆäŽOŽ}, ‰z–ìD•¶, “ŒŠÔ³l, ’·àV’B–ç, A–Ø ², ‘å’Ë”üŒbŽq, –ØÈŽO, ˆÉŽºLÆ, X ‘¥•v, •ˆä‹³Žg, ¯–ì—Ljê, ŽO•Ó‹`—Y, “ï”g‹g—Y, “ï”g^‹|, ‹g—Ljê, ‘唪–Ø•Û­, Œ´‰ª åõ, HŒ³Ž¡˜N, ŽO‰YL‹`, –Ø‘ºTŒá, ¼‰º³–¾ (2002): ¢ƒA[ƒoƒ“ƒX(RBANS)£_ŒoS—ƒeƒXƒg‚É‚æ‚é‚ŽŸ”]‹@”\•]‰¿. ”]‚Æ_Œo, 54, 463-471.

  20. Rivermead behavioural memory test (RBMT)
    1) Wilson BACCockburn JMCBaddeley AD (1986): Rivermead behavioural memory test. suppl 2 –ÈXiŽqEŒ´ Š°”üE‹{XFŽjE]“¡•¶•v (2002): “ú–{”ÅRBMTƒŠƒo[ƒ~[ƒhs“®‹L‰¯ŒŸ¸ ç—tƒeƒXƒgƒZƒ“ƒ^[
    2) Kazui H, Matsuda A, Hirono N, Mori E, Miyoshi N, Ogino A, Tokunaga H, Ikejiri Y, Takeda M (2005): Everyday memory impairment of patients with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 19, 331-337.
    3) ¼“c–¾”üE”ˆä—TŒõE”Ž–ìMŽŸEX ‰x˜N (2002): ŒyǃAƒ‹ƒcƒnƒCƒ}[•aŠ³ŽÒ‚É‚¨‚¯‚郊ƒo[ƒ~[ƒhs“®‹L‰¯ŒŸ¸‚Ì—L—p«. ”]‚Æ_Œo, 54, 673-678.

  21. Senior Apperception Technique (SAT)
    1) Bellak LCBellak SS (1973): Manual for the Senior Apperception Technique (SAT)DCPSCNew York. Ž™‹Ê È(–ó) (1978): SAT‚”NŽÒŠG‰æ“ŠoŒŸ¸Žèˆø “ú–{•¶‰»‰ÈŠwŽÐ

  22. Sentence Completion Test (SCT)
    1) ‰º’‡‡ŽqE‘º£F—Y (1975): SCT‚É‚æ‚é˜Vl‚ÌŽ©ŒÈŠT”O‚ÌŒ¤‹†.‹³ˆçS—ŠwŒ¤‹†, 23, 104-113.

  23. Standard verbal paired-associate learning test (S-PA:•W€Œ¾Œê«‘ΘA‡ŠwKŒŸ¸)
    1) “ú–{‚ŽŸ”]‹@”\áŠQŠw‰ï(•Ò)C“ú–{‚ŽŸ”]‹@”\áŠQŠw‰ï Brain Function TestˆÏˆõ‰ï V‹L‰¯ŒŸ¸ì»¬ˆÏˆõ‰ï(’˜) (2014): •W€Œ¾Œê«‘ΘA‡ŠwKŒŸ¸. V‹»ˆãŠwo”ÅŽÐ

  24. Unilateral Spatial Neglect(USN)ƒeƒXƒg
    1) Albert ML (1973): A simple test of visual neglect. Neurology 23; 658-664.
    2) ‹v•Û_ˆê (1980): ”¼‘¤‹óŠÔŽ¸”F. _Œoi•à 24; 598-609.(ŠG‚ÌŒÄÌ, }Œ`EŠG‚Ì–ÍŽÊ, “Ç‚Ý, ‘Žš)

  25. ŽO‘Œ¾Œê‹L–Á—ÍŒŸ¸
    1) ŽO‘îèiˆêE“à“c—EŽO˜Y (1924a): ‹L‰¯‚Éè‚·‚é—ÕଓI›‰é„¬Ñ(ã)D_ŒoŠwŽGŽ, 23, 458-488.
    2) ŽO‘îèiˆêE“à“c—EŽO˜Y (1924b): ‹L‰¯‚Éè‚·‚é—ÕଓI›‰é„¬Ñ(’†)D_ŒoŠwŽGŽ, 23, 523-565.
    3) ŽO‘îèiˆêE“à“c—EŽO˜Y (1924c): ‹L‰¯‚Éè‚·‚é—ÕଓI›‰é„¬Ñ(‰º)D_ŒoŠwŽGŽ, 24, 12-45.

  26. Wechsler Memory Scale (WMS)
    1) Wechsler D (1945): A standardized memory scale for clinical useDJ Psychol, 19, 87-95.

_ŒoS—Šw

  1. Cummings JL (1993): Frontal-subcortical circuits and human behavior. Archives of Neurology, 50, 873-880.

  2. Narumoto JCYamada HCIidaka TCSadato NCFukui KCItoh HCYonekura Y (2000): Brain regions involved in verbal or non-verbal aspects of facial emotion recognition. Neuroreport, 11(11), 2571-76.

  3. Narumoto JCOkada TCSadato NCFukui KCYonekura Y (2001): Attention to emotion modulates fMRI activity in human right superior temporal sulcusDBrain Res Cogn Brain Res, 12(2), 225-31.

  4. Squire LR, Zola SM (1996): Structure and function of declarative and nondeclarative memory systems. Proceedings of National Academy of Sciences of the United States of America, 93, 13515-13522.

”F’mÇ

  1. American Psychiatric Association (1997): Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late lifeDAm J Psychiatry, 154;suppl 5, 1-39.

  2. American Psychiatric Association Work Group on Alzheimer's Disease and Other Dementias (2007): American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry, 164;suppl 12, 5-56.

  3. Amieva H, Le Goff M, Milet X, Orgogozo JM, Peres K, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF (2008): Prodromal Alzheimer's diseaseFsuccessive emergence of the clinical symptomsDAnn Neurol, 64, 492-498.

  4. Levy DA, Bayler PJ, Squire LR (2004): The anatomy of semantic knowledge: medial vs. lateral temporal lobeDProc Natl Acad Sci USA, 101, 6710-6715.

  5. Noppeney U, Patterson K, Tyler LK, Tyler K, Moss H, Stamatakis EA, Bright P, Mummery C, Price CJ (2007): Temporal lobe lesions and semantic impairmentFa comparison of herpes simplex virus encephalitis and semantic dementiaDBrain, 130,1138-1147.

  6. Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M (2003): Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controllled trial. Br J Psychiatry, 183, 248-254.

”­’BáŠQ

  1. Amen DG, Carmichael BD: High-resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry, 9: 81-86, 1997.

  2. Baron-Cohen S, Leslie AM, Frith U: Does the autistic child have a "theory of mind"?@CognitionC21: 37-46, 1985.

  3. Baron-Cohen S, Ring HA, Wheelwright S, Bullmore ET, et al.: Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci, 11; 1891-1898, 1999.

  4. Durston S, Tottenham NT, Thomas KM, Davidson MC, et al.: Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatry, 53; 871-878, 2003.

  5. Ernst M, Zametkin AJ, Matochik JA, Jons PH, et al.: DOPA decarboxylase activity in attention deficit hyperactivity disorder adults: a [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci, 18; 5901-5907, 1998.

  6. Fletcher PC, Happe F, Frith U, Baker SC, et al.: Other minds in the brain: a functional imaging study of "theory of mind" in story comprehensionDCognition, 57; 109-128, 1995.

  7. Happe F, Ehlers S, Fletcher P, Frith U, et al.: 'Theory of mind' in the brain: evidence from a PET scan study of Asperger syndrome. Neuroreport, 8; 197-201, 1996.

  8. Inoue H, Yamasue H, Tochigi M, Abe O, et al.: Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biol Psychiatry, 68; 1066-1072, 2010.

  9. Kuwabara H, Kasai K, Takizawa R, Kawakubo Y, et al.: Decreased prefrontal activation during letter fluency task in adults with pervasive developmental disorders: a near-infrared spectroscopy study. Behav Brain Res, 172; 272-277, 2006.

  10. Rodrigues SM, Saslow LR, Garcia N, John OP, et al.: Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci USA, 106; 21437-21441, 2009.

  11. Yamasue H, Ishijima M, Abe O, Sasaki T, et al.: Neuroanatomy in monozygotic twins with Asperger disorder discordant for comorbid depression. Neurology, 65; 491-492, 2005.

  12. Yamasaki S, Yamasue H, Abe O, Suga M, et al.: Reduced gray matter volume of pars opercularis is associated with impaired social communication in high-functioning autism spectrum disorders. Biol Psychiatry, 68; 1141-1147, 2010.

    b@@go top@@b